Farms.com Home   News

UC Davis Part of Group Awarded $1.5 Million Cooperative Agreement From FDA

UC Davis Part of Group Awarded $1.5 Million Cooperative Agreement From FDA

By Rob Warren

The UC Davis School of Veterinary Medicine is one of five partner institutions with the National Institute of Antimicrobial Resistance Research and Education to receive a $1.5 million cooperative agreement award from the U.S. Food and Drug Administration Center for Veterinary Medicine to support a project designed to improve antibiotic stewardship by prioritizing the most significant diseases in food animal production and identifying alternative treatment strategies.

The funding will support research using a multi-pronged, standardized methodology to identify diseases that drive the most use of antibiotics in three major livestock species (swine, chickens [broiler], and cattle [dairy and beef]) as well as to identify antimicrobial alternatives in these production animals that may reduce reliance on antimicrobial drugs.

Source : ucdavis.edu

Trending Video

Unveiling a Breakthrough Genetic Solution for Future-Proof, Sustainable Pork Production

Video: Unveiling a Breakthrough Genetic Solution for Future-Proof, Sustainable Pork Production


Marcel Huijsmans, Global Marketing Director at Topigs Norsvin tells us about their new genetic solution R3silience that offers a solid alternative to how the industry can approach disease management.

R3silience delivers scientifically proven, naturally resilient pigs that thrive under disease pressure, enabling more predictable, sustainable production by reducing losses and sustaining growth under disease challenge.

R3silience pigs deliver higher survival, stronger overall performance, and healthier herds - reducing wean-to-finish mortality by up to 6 percentage points during multifactorial PRRS outbreak*.

R3silience pigs not only show higher survival, but also deliver superior growth, improving daily weight gain by up to 0.04lbs. per day under multifactorial PRRS outbreak.*

Pigs with enhanced resilience to both viral and bacterial diseases require fewer health interventions and up to 8% less antibiotic treatments from wean-to-finish*, supporting better animal welfare.

For more information visit https://topigsnorsvin.com/products/r3...